We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$32.2B
AUM Growth
+$1.15B
Cap. Flow
+$886M
Cap. Flow %
2.75%
Top 10 Hldgs %
14.34%
Holding
3,060
New
26
Increased
2,469
Reduced
354
Closed
63

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$23.3M
2
XOM icon
ExxonMobil
XOM
+$22.8M
3
AAPL icon
Apple
AAPL
+$21.5M
4
WFC icon
Wells Fargo
WFC
+$19.8M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$17.3M

Sector Composition

Rank Sector Weight
1 Technology 14.4%
2 Financials 14.39%
3 Healthcare 13.67%
4 Industrials 10.84%
5 Consumer Discretionary 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEFF
2901
DELISTED
Neff Corporation
NEFF
$96K ﹤0.01%
12,915
+730
+6% +$3.92K
KEG
2902
DELISTED
KEY ENERGY SERVICES INC
KEG
$94K ﹤0.01%
254,113
+3,735
+1% +$1.38K
CRMD icon
2903
CorMedix
CRMD
$590M
$93K ﹤0.01%
6,987
+1,010
+17% +$9.8K
PMTS icon
2904
CPI Card Group
PMTS
$263M
$93K ﹤0.01%
+2,256
New +$94.2K
UUUU icon
2905
Energy Fuels
UUUU
$3.21B
$93K ﹤0.01%
42,239
+2,705
+7% +$6.28K
EPE
2906
DELISTED
EP Energy Corporation
EPE
$92K ﹤0.01%
20,360
-4,300
-17% -$15.8K
MFIC icon
2907
MidCap Financial Investment
MFIC
$799M
$91K ﹤0.01%
5,454
+27
+0.5% +$417
CALA
2908
DELISTED
Calithera Biosciences, Inc
CALA
$91K ﹤0.01%
805
+77
+11% +$8.72K
CPRX
2909
DELISTED
Catalyst Pharmaceutical
CPRX
$90K ﹤0.01%
76,641
+1,425
+2% +$2.21K
VATE icon
2910
INNOVATE Corp
VATE
$106M
$90K ﹤0.01%
2,353
+413
+21% +$15.9K
TCS
2911
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$89K ﹤0.01%
1,014
AMBR
2912
DELISTED
Amber Road Inc
AMBR
$89K ﹤0.01%
16,529
+170
+1% +$785
FNM
2913
DELISTED
FANNIE MAE
FNM
$89K ﹤0.01%
63,500
STCN
2914
DELISTED
Steel Connect, Inc. Common Stock
STCN
$88K ﹤0.01%
6,445
+568
+10% +$10.3K
FRE
2915
DELISTED
FREDDIE MAC D/B/A VOTING
FRE
$88K ﹤0.01%
66,008
XOMA
2916
DELISTED
Xoma
XOMA
$87K ﹤0.01%
5,647
+106
+2% +$1.91K
IMBI
2917
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$87K ﹤0.01%
7,464
+703
+10% +$6.63K
VTAE
2918
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$85K ﹤0.01%
12,836
+100
+0.8% +$909
ACW
2919
DELISTED
Accuride Corp
ACW
$84K ﹤0.01%
53,950
UNIS
2920
DELISTED
Unilife Corporation
UNIS
$83K ﹤0.01%
12,139
+226
+2% +$1.95K
GUID
2921
DELISTED
Guidance Software, Inc.
GUID
$82K ﹤0.01%
19,100
SGY
2922
DELISTED
Stone Energy
SGY
$82K ﹤0.01%
1,827
+210
+13% +$27.1K
GNMX
2923
DELISTED
Aevi Genomic Medicine Inc
GNMX
$81K ﹤0.01%
18,385
+200
+1% +$823
ABCD
2924
DELISTED
Cambium Learning Group, Inc.
ABCD
$80K ﹤0.01%
18,731
+1,840
+11% +$8.05K
DRNA
2925
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$78K ﹤0.01%
14,463

Similar funds

RhumbLine Advisers's Q1 2016 Portfolio in Review

As of Q1 2016, RhumbLine Advisers held 3,060 positions worth $32.2B, up 3.7% from $31.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2016: portfolio turnover was 2.9%. RhumbLine Advisers opened 26 new positions and exited 63, leaving the 3,060-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2016 buy was Willis Towers Watson: 89,353 shares worth $10.6M.
  • RhumbLine Advisers added most to Broadcom in Q1 2016, an estimated $23.3M increase.
  • RhumbLine Advisers's biggest Q1 2016 reduction was Chubb, cutting an estimated $13.7M.
  • RhumbLine Advisers fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $43M.
  • RhumbLine Advisers's ten largest holdings make up 14% of its $32.2B portfolio in Q1 2016.
  • RhumbLine Advisers opened 26 new positions and closed 63 in Q1 2016.
  • RhumbLine Advisers's portfolio value rose 3.7% quarter-over-quarter to $32.2B.

Based on RhumbLine Advisers's 13F filing for Q1 2016, filed 2 May 2016.